CDC issues global dengue alert as Americas see renewed rise

The United States Centers for Disease Control and Prevention has issued an updated global dengue travel notice following renewed increases in dengue activity across parts of the Americas, prompting fresh guidance for travelers planning trips to affected destinations in late 2026.

Global dengue risk prompts new CDC travel notice

According to publicly available information from the CDC’s Travelers’ Health pages, the agency updated a Global Dengue Travel Health Notice on November 10, 2026. The notice highlights that dengue remains a year-round risk in many tropical and subtropical regions and that some countries are reporting higher than expected transmission this year compared with usual seasonal patterns.

The CDC indicates that dengue is now common across large parts of the Americas, Africa, the Middle East, South and Southeast Asia, and many Pacific islands. The agency notes that outbreaks tend to occur every two to five years, but that recent seasons have seen unusually high case numbers in several regions, including the Americas, where dengue has reached record or near-record levels since 2023.

The updated travel notice is global in scope, but specific alerts are also in place for individual countries where reported case counts or reports involving returning travelers are elevated. Countries in Latin America and the Caribbean feature prominently on this list, reflecting data supplied by national health ministries and regional partners.

CDC travel health notices do not restrict travel but are designed to inform travelers of changing risks and to recommend steps they can take to protect themselves before, during, and after a trip.

Americas face renewed increases after record 2024 outbreak

Regional reports from the Pan American Health Organization show that the Americas are still recovering from an unprecedented dengue surge in 2024, when more than 13 million suspected cases and over 8,000 deaths were documented across the region. Follow up reporting indicates that 2025 case totals fell to around one third of that historic peak but remained higher than typical non-epidemic years, with more than 4.4 million cases recorded.

PAHO situation updates for 2026 describe dengue activity that began the year at lower levels than 2024 and 2025, but that has risen again in several countries as the Southern Hemisphere warm and rainy season approaches. Reports released in October 2026 note increases in parts of the Andean region, Central America, and the Caribbean, with circulation of multiple dengue virus serotypes in some countries.

Regional monitoring classifies the current situation as a multi-country outbreak that still requires an emergency-level response. While overall case numbers reported so far in 2026 remain below the 2024 peak, surveillance data show that incidence in some areas is already above the five-year average for the same time of year, raising concern that another intense season may be developing.

Publicly available documents from PAHO also highlight the role of climate patterns such as El Niño, urbanization, and the spread of Aedes mosquitoes in sustaining dengue transmission across the hemisphere. Health ministers in the Americas approved a new regional strategy in October 2026 aimed at strengthening surveillance, early diagnosis, and integrated vector control through 2035.

What the notice means for travelers

The CDC’s global dengue travel notice advises travelers to destinations with dengue risk to consult health providers at least four to six weeks before departure. The agency emphasizes that many dengue infections are mild or without symptoms but that some can progress to severe disease, particularly in people who have been infected before with a different dengue virus serotype.

Current public guidance underscores that there is no widely available antiviral treatment that can cure dengue. Care focuses on managing symptoms and preventing complications, making early recognition important for anyone who develops sudden fever, severe headache, pain behind the eyes, muscle and joint pain, nausea, or rash within two weeks of being in an area where dengue circulates.

The notice reiterates that preventing mosquito bites remains the primary way for most travelers to reduce risk. The CDC recommends using insect repellent registered with national regulators, wearing long sleeves and long pants in areas with mosquitoes, and choosing accommodations with air conditioning or intact window and door screens. Travelers are advised that mosquitoes capable of spreading dengue often live in and around homes and bite during the day, not only at night.

Information provided by the CDC also cautions that travelers who have recently had dengue and then return to areas where the virus circulates may face higher risk of severe disease if they are infected again with a different serotype. People with underlying medical conditions or who are pregnant are encouraged to discuss travel plans and risk tolerance in detail with a clinician.

Countries and regions drawing particular concern

The CDC’s travel health notice system currently lists a number of individual dengue notices for countries where transmission is higher than usual, alongside the global advisory. Recent entries highlight several destinations in Latin America and the Caribbean, including countries such as Colombia, Peru, Ecuador, Panama, Costa Rica, and some islands in the Caribbean, among others, reflecting increased transmission or higher than expected case numbers among travelers.

Regional updates from PAHO indicate that circulation of all four dengue serotypes has been documented in the Americas over the last two years, increasing the likelihood of alternating waves of transmission. In some countries, health authorities have reported a shift in the predominant serotype compared with earlier seasons, which can contribute to new surges of cases in populations that have not recently been exposed to that particular strain.

Elsewhere in the world, public reporting from the World Health Organization and regional agencies points to substantial dengue activity in parts of Southeast Asia and the Western Pacific during 2026, with weekly case counts in some countries remaining above epidemic thresholds even as peak season subsides. These trends underpin the CDC’s decision to maintain a global scope for the current dengue travel notice rather than limiting concern to one continent.

Travelers planning multi-country itineraries that combine destinations in the Americas with stops in Asia or the Pacific may therefore encounter dengue risks in multiple legs of their journey. Health agencies recommend that travelers review the latest country-specific information shortly before departure, as local risk levels can change within weeks based on rainfall, temperature, and mosquito control efforts.

Practical planning tips for upcoming trips

In response to the renewed CDC notice, travel medicine specialists and public health agencies are reinforcing practical steps that travelers can take when visiting dengue-affected areas. Guidance commonly includes packing sufficient insect repellent, considering permethrin-treated clothing or gear, and confirming that lodgings have screens or bed nets where needed.

Public information from health agencies also suggests checking whether local destinations are at elevations where dengue risk is lower. Mosquitoes capable of transmitting dengue generally do not thrive above approximately 2,000 meters, although travelers are encouraged to verify local conditions, particularly in cities that combine high-altitude neighborhoods with lower surrounding areas.

Travelers are further advised to purchase comprehensive travel health insurance that covers medical care abroad and emergency evacuation, especially when visiting remote beach areas, islands, or rural destinations where health services may be limited. Insurance documents should be carried in an accessible form so that travelers can seek care quickly if they develop symptoms compatible with dengue after exposure to mosquito bites.

Health agencies stress that the updated global dengue travel notice is intended to increase awareness and encourage preparation rather than to discourage tourism. For many destinations in the Americas, travel remains open and popular, with local authorities working to strengthen surveillance and vector control. By staying informed about current advisories, taking bite-prevention measures seriously, and seeking prompt medical evaluation for fever or flu-like symptoms after travel, visitors can significantly reduce the personal impact of dengue while still enjoying trips throughout the region.